BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37533789)

  • 1. S100A9 Regulated M1/M2 Macrophage Polarization in Interleukin-10-Induced Promotion of Malignant Pleural Effusion.
    Pei XB; Yi FS; Dong SF; Chen QY; Shi XY
    J Immunol Res; 2023; 2023():3473464. PubMed ID: 37533789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chinese medicine Xiaoshui decoction inhibits malignant pleural effusion in mice and mediates tumor-associated macrophage polarization by activating autophagy.
    Jin Z; Shen C; Zhang H; Qi R; Guo Q; Liu R; Hua B; Shi Z
    J Ethnopharmacol; 2020 Mar; 249():112412. PubMed ID: 31751649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer.
    Wu MF; Lin CA; Yuan TH; Yeh HY; Su SF; Guo CL; Chang GC; Li KC; Ho CC; Chen HW
    Cancer Immunol Immunother; 2021 May; 70(5):1435-1450. PubMed ID: 33175182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSAd Plays a Major Role in Myo9b-Mediated Suppression of Malignant Pleural Effusion by Regulating T
    Yi FS; Zhang X; Zhai K; Huang ZY; Wu XZ; Wu MT; Shi XY; Pei XB; Dong SF; Wang W; Yang Y; Du J; Luo ZT; Shi HZ
    J Immunol; 2020 Nov; 205(10):2926-2935. PubMed ID: 33046503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.
    Yang L; Wang F; Wang L; Huang L; Wang J; Zhang B; Zhang Y
    Oncotarget; 2015 Apr; 6(12):10592-603. PubMed ID: 25871392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion.
    Wang D; Yang L; Yue D; Cao L; Li L; Wang D; Ping Y; Shen Z; Zheng Y; Wang L; Zhang Y
    Cancer Lett; 2019 Jun; 452():244-253. PubMed ID: 30928379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-10 promotes malignant pleural effusion in mice by regulating T
    Wu XZ; Zhai K; Yi FS; Wang Z; Wang W; Wang Y; Pei XB; Shi XY; Xu LL; Shi HZ
    Eur J Immunol; 2019 Apr; 49(4):653-665. PubMed ID: 30695099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF1/CSF1R signaling mediates malignant pleural effusion formation.
    Kosti CN; Vaitsi PC; Pappas AG; Iliopoulou MP; Psarra KK; Magkouta SF; Kalomenidis IT
    JCI Insight; 2022 Mar; 7(6):. PubMed ID: 35315360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-26 promotes the pathogenesis of malignant pleural effusion by enhancing CD4
    Niu Y; Ye L; Peng W; Wang Z; Wei X; Wang X; Li Y; Zhang S; Xiang X; Zhou Q
    J Leukoc Biol; 2021 Jul; 110(1):39-52. PubMed ID: 33847412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-derived exosome promotes regulatory T cell differentiation in malignant pleural effusion.
    Shao MM; Pei XB; Chen QY; Wang F; Wang Z; Zhai K
    Front Immunol; 2023; 14():1161375. PubMed ID: 37143656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A9 promotes tumor-associated macrophage for M2 macrophage polarization to drive human liver cancer progression: An in vitro study.
    Yang LF; Zhang ZB; Wang L
    Kaohsiung J Med Sci; 2023 Apr; 39(4):345-353. PubMed ID: 36807724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
    Stathopoulos GT; Psallidas I; Moustaki A; Moschos C; Kollintza A; Karabela S; Porfyridis I; Vassiliou S; Karatza M; Zhou Z; Joo M; Blackwell TS; Roussos C; Graf D; Kalomenidis I
    J Natl Cancer Inst; 2008 Oct; 100(20):1464-76. PubMed ID: 18840818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusion.
    Magkouta S; Pappas A; Moschos C; Vazakidou ME; Psarra K; Kalomenidis I
    Oncotarget; 2016 Apr; 7(15):20249-59. PubMed ID: 26959120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17 inhibits development of malignant pleural effusion via interleukin-9-dependent mechanism.
    Lu Y; Lin H; Zhai K; Wang X; Zhou Q; Shi H
    Sci China Life Sci; 2016 Dec; 59(12):1297-1304. PubMed ID: 27535421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-10 promotes malignant pleural effusion by regulating T
    Zhai K; Shi XY; Yi FS; Huang ZY; Wu XZ; Dong SF; Wang W; Wu MT; Shi HZ
    Eur J Immunol; 2020 Nov; 50(11):1798-1809. PubMed ID: 32506440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization.
    Philipp D; Suhr L; Wahlers T; Choi YH; Paunel-Görgülü A
    Stem Cell Res Ther; 2018 Oct; 9(1):286. PubMed ID: 30359316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion.
    Stathopoulos GT; Sherrill TP; Karabela SP; Goleniewska K; Kalomenidis I; Roussos C; Fingleton B; Yull FE; Peebles RS; Blackwell TS
    Am J Respir Crit Care Med; 2010 Nov; 182(10):1273-81. PubMed ID: 20595227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the Small Noncoding RNAome During M1 and M2 Macrophage Polarization.
    Ma D; Zhou X; Wang Y; Dai L; Yuan J; Peng J; Zhang X; Wang C
    Front Immunol; 2022; 13():799733. PubMed ID: 35619693
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Hu L; Liu Y; Kong X; Wu R; Peng Q; Zhang Y; Zhou L; Duan L
    Front Immunol; 2021; 12():658681. PubMed ID: 34093546
    [No Abstract]   [Full Text] [Related]  

  • 20. Impaired T cell function in malignant pleural effusion is caused by TGF-β derived predominantly from macrophages.
    Li L; Yang L; Wang L; Wang F; Zhang Z; Li J; Yue D; Chen X; Ping Y; Huang L; Zhang B; Zhang Y
    Int J Cancer; 2016 Nov; 139(10):2261-9. PubMed ID: 27459735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.